| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, See Remarks And Footnotes | Director, See Explanation Of Responses +5 more
17 companies
Bvf Partners L P/il is a 10% Owner at CALA with holdings across 17 companies. Recent SEC Form 4 filings include 27 buys and 9 sells.
Estimated insider holdings value: $419.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | KYMR Kymera Therapeutics, Inc. | Director, See Remarks And Footnotes | Buy | 317,167 | $44.00 | $13,955,348.00 | +6.3% | +34.1% | - | |
| May 16, 2025 | XOMA Xoma Royalty Corp | 10% Owner | Sell | 392,723 | $27.10 | $10,642,793.30 | -13.2% | +17.0% | - | |
| Jan 24, 2025 | XOMA Xoma Royalty Corp | 10% Owner | Sell | 650,717 | $26.10 | $16,983,713.70 | -17.9% | -9.3% | 0.0% | |
| Oct 4, 2024 | MLTX Moonlake Immunotherapeutics | Director, 10% Owner | Sell | 2,000,000 | $50.00 | $100,003,200.00 | -9.2% | -3.1% | -84.8% | |
| May 9, 2024 | ELDN Eledon Pharmaceuticals, Inc. | 10% Owner | Buy | 1,927,937 | $0.00 | - | +45.0% | +8.3% | +20.4% | |
| Nov 16, 2023 | RPTX Repare Therapeutics Inc. | 10% Owner | Buy | 1,227,301 | $5.09 | $6,249,889.20 | +6.5% | +22.5% | -44.1% | |
| Nov 3, 2023 | KYMR Kymera Therapeutics, Inc. | Director, See Remarks And Footnotes | Buy | 414,105 | $12.80 | $5,301,325.49 | +4.4% | +129.0% | +225.6% | |
| Nov 2, 2023 | RPTX Repare Therapeutics Inc. | 10% Owner | Buy | 783,709 | $3.60 | $2,821,352.40 | +9.6% | +80.7% | -1.1% | |
| Sep 12, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,505,932 | $9.84 | $14,818,370.88 | +20.7% | -4.4% | +3.1% | |
| May 5, 2023 | ELDN Eledon Pharmaceuticals, Inc. | 10% Owner | Buy | 1,978,932 | $0.00 | - | +85.7% | -51.5% | -10.1% |